trending Market Intelligence /marketintelligence/en/news-insights/trending/T392ITSo9iwNNmi13JnGcw2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Evertex fabrinology Q4 profit falls YOY

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

COVID-19 Impact & Recovery: LCD Outlook for H2 2021

Blog

COVID-19 Impact & Recovery: Technology Outlook for H2 2021

Blog

COVID-19 Impact & Recovery: Financial Industry Outlook for H2 2021


Evertex fabrinology Q4 profit falls YOY

evertex fabrinology Ltd. said its fourth-quarter normalized net income amounted to 16 Taiwan cents per share, a decline of 11.7% from 18 cents per share in the year-earlier period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was NT$13.8 million, a decrease of 11.6% from NT$15.6 million in the prior-year period.

The normalized profit margin fell to 7.5% from 8.1% in the year-earlier period.

Total revenue declined on an annual basis to NT$183.7 million from NT$191.7 million, and total operating expenses decreased year over year to NT$163.9 million from NT$169.0 million.

Reported net income declined 12.4% from the prior-year period to NT$18.1 million, or 21 cents per share, from NT$20.6 million, or 24 cents per share.

For the year, the company's normalized net income totaled 55 cents per share, a decline from 57 cents per share in the prior year.

Normalized net income was NT$47.6 million, a fall from NT$48.9 million in the prior year.

Full-year total revenue increased year over year to NT$761.7 million from NT$744.3 million, and total operating expenses rose on an annual basis to NT$692.6 million from NT$673.4 million.

The company said reported net income decreased 7.8% year over year to NT$61.0 million, or 71 cents per share, in the full year, from NT$66.1 million, or 77 cents per share.

As of March 29, US$1 was equivalent to NT$32.58.